Literature DB >> 6645591

Left atrium-to-femoral artery bypass: effectiveness in reduction of acute experimental myocardial infarction.

F P Catinella, J N Cunningham, E Glassman, J C Laschinger, F G Baumann, F C Spencer.   

Abstract

The effects of prompt institution of left atrium-to-femoral artery (LA-FA) bypass on myocardial infarct area (AI) as a percentage of myocardial area at risk for infarction (AR) during a 4 hour period following ligation of the left anterior descending coronary artery (LAD) were studied in 26 dogs. Following LAD ligation, baseline measurements of myocardial tension-time index (TTI) and regional myocardial blood flow (RMBF) were obtained. Group I (controls, n = 16) received no further support. Group II (LA-FA bypass, n = 10) underwent left ventricular unloading via LA-FA bypass beginning 15 minutes after coronary occlusion. Four hours after LAD occlusion, measurements of TTI and RMBF were repeated in both groups. Just before sacrifice, gentian violet was injected into the aortic root to delineate the AR. The hearts were then removed and sectioned transversely through the left ventricle (LV) and septum. The AR (that ventricular area not perfused by gentian violet) was measured by planimetry and compared to the AI as identified by incubation of heart slices in triphenyltetrazolium chloride dye. In comparisons of control versus LA-FA bypass groups, both AI/LV (21.6% versus 10.4%) and AI/AR ratios (73.7% versus 21.8%) were significantly reduced in the bypass group (p less than 0.005). Mortality in the control group (5/16, 31.2%) was significantly greater (p less than 0.005) than in the bypass group (0/10, 0%). Mean TTI over the 4 hour ischemic period was essentially unchanged in the control group as compared to a reduction of 62.8% in the bypass group (p less than 0.005). Furthermore, RMBF at 4 hours was significantly improved in all regions of the LV in hearts undergoing LA-FA bypass when compared with control hearts (p = 0.025). These results demonstrate by a consistent method that prompt institution of LA-FA bypass significantly reduces the mortality associated with acute coronary artery occlusion, as well as the total AI and AI/AR. The protective mechanisms provided by LA-FA bypass probably include the highly significant reduction of LV work and the opening of new bridge collateral blood vessels with redistribution of blood flow to the ischemic region.

Entities:  

Mesh:

Year:  1983        PMID: 6645591

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Experimental and clinical results with a simplified left heart assist device for treatment of profound left ventricular dysfunction.

Authors:  D M Rose; J Laschinger; E Grossi; K H Krieger; J N Cunningham; F C Spencer
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

Review 2.  Mechanical Left Ventricular Unloading to Reduce Infarct Size During Acute Myocardial Infarction: Insight from Preclinical and Clinical Studies.

Authors:  Navin K Kapur; Lara Reyelt; Lija Swain; Michele Esposito; Xiaoying Qiao; Shiva Annamalai; Bart Meyns; Richard Smalling
Journal:  J Cardiovasc Transl Res       Date:  2019-04-23       Impact factor: 4.132

3.  The effect of the left ventricular assist device on the myocardium during reperfusion after coronary artery occlusion.

Authors:  N Matsumoto; M Miyamoto; F Mori; K Esato
Journal:  Jpn J Surg       Date:  1990-05

4.  Mechanical Unloading of the Left Ventricle before Coronary Reperfusion in Preclinical Models of Myocardial Infarction without Cardiogenic Shock: A Meta-Analysis.

Authors:  Stefano Benenati; Gabriele Crimi; Andrea Macchione; Corinna Giachero; Fabio Pescetelli; Manrico Balbi; Italo Porto; Matteo Vercellino
Journal:  J Clin Med       Date:  2022-08-21       Impact factor: 4.964

Review 5.  The role of acute circulatory support in ST-segment elevation myocardial infarction complicated by cardiogenic shock.

Authors:  Michele Esposito; Yousef Bader; Robert Pedicini; Catalina Breton; Andrew Mullin; Navin K Kapur
Journal:  Indian Heart J       Date:  2017-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.